Sanbo Brain Hospital

What Sanbo Brain Hospital does

Sanbo Brain Hospital (首都医科大学三博脑科医院) is a Beijing-headquartered specialty neurosurgery hospital group that diagnoses and treats complex neurological conditions referred from across China. Founded in 2004 by a group of senior neurosurgeons, the Group operates a flagship hospital affiliated with Capital Medical University (the 11th Clinical Medical College) plus eight regional branches in Kunming, Chongqing, Changsha, Xi'an, Luoyang, Fujian, Henan, and Shaanxi — nine sites in total. Core clinical departments cover epilepsy surgery, functional neurosurgery, skull base surgery, supratentorial tumor surgery, cerebrovascular surgery and intervention, pediatric neurosurgery, spinal/spine surgery, endoscopic minimally invasive neurosurgery, neuro-oncology chemotherapy, and neurology, supported by a Sanbo Brain Research Institute and a certified Drug Clinical Trial Institution.

Technology platforms are centered on Asia's first ROSA robot stereotactic system, a 306-channel whole-head magnetoencephalography (MEG) system, surgical navigation, video EEG, and high-resolution MRI, with proprietary software copyrights for neurophysiological diagnosis, MEG information management, angiography X-ray, and vagus nerve stimulation. The Group holds a National Clinical Key Specialty designation in neurosurgery — held by only 28 private hospitals in China — and has accumulated 7,400+ intracranial tumor surgeries, 6,500+ epilepsy surgeries, and a craniopharyngioma program with 1,200+ cases and a 95% complete resection rate, the highest volume and outcomes reported globally. Lead expert Professor Luan Guoming has published 100+ SCI papers and personally performed 10,000+ neurosurgical operations.

Sanbo generates revenue by delivering specialized neurosurgical and neurological services under the Beijing medical insurance pricing framework, with cross-regional settlement for out-of-province patients and a separate international consultation tier; ancillary streams include drug/medical device clinical trials and a telemedicine consultation center launched in 2015 that has served 500+ patients. Distribution is primarily direct through hospital visits (appointments via phone and WeChat), remote video consultation, and medical consortium referrals with regional partner hospitals. Following a ~$113M Series B in May 2020, the Group listed on the Shenzhen Stock Exchange ChiNext board in May 2023, completed a strategic partnership with Beijing Borun Sunshine in July 2025, and relocated its Beijing headquarters to a new Dongba campus in early 2026.

Name

Sanbo Brain Hospital

Legal name

首都医科大学三博脑科医院

Website

https://sbnk.cn

Company type

Public

Founded year

2004

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Sanbo Brain Hospital (首都医科大学三博脑科医院) is a Beijing-headquartered, publicly listed specialty neurosurgery hospital group operating nine sites across China, treating complex neurological conditions including epilepsy, brain tumors, cerebrovascular disease, and pediatric neurosurgery.

Ownership category

akta.pro rank

Product category

Specialized Neurosurgery and Neurology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Neurology & Neurosurgical Specialty Hospitals (HLAFAHAD)

akta.pro secondary industries

Epilepsy & Seizure Disorders (HLAKAIAB), Pediatric Neurology (HLAKAIAK), Neurorehabilitation Centers (HLAFAFAH)

Keywords

• Neurosurgery services
• Neurological disease treatment
• Brain tumor surgery
• Epilepsy surgical care
• Cerebrovascular surgery

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices10 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Services Revenue: The hospital generates revenue through providing specialized neurological and neurosurgical medical services including consultations, surgeries, hospitalizations, and diagnostic procedures. As a medical institution, it operates under the national medical insurance system and serves both domestic patients and international patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Sanbo Brain Hospital is a specialized neurology and neurosurgery hospital that provides diagnosis, surgical treatment, and inpatient care for complex neurological conditions, including intracranial tumors, drug-resistant epilepsy, cerebrovascular diseases, movement disorders, pediatric neurological disorders, and spinal cord/spine diseases. It delivers these services through more than 20 clinical departments and specialized centers across a network of nine hospitals in China, supported by advanced equipment such as Asia's first ROSA robot stereotactic system and a 306-channel magnetoencephalography system.

Product overview

Sanbo Brain Hospital (首都医科大学三博脑科医院) is a specialized neurology and neurosurgery hospital offering comprehensive medical services through multiple clinical departments and specialized centers. The hospital provides a portfolio of 22+ clinical services including epilepsy surgery, functional neurosurgery, skull base surgery, cerebrovascular surgery, pediatric neurosurgery, spinal cord/spine surgery, and neuro-oncology. Supporting services include diagnostic departments (magnetoencephalography, neuroradiology), research institutes (brain research institute, epilepsy clinical laboratory), and clinical trial services. The hospital operates as part of the Sanbo Brain Hospital Management Group with branches in Kunming, Xi'an, Changsha, Luoyang, and Chongqing.

Differentiator

Problem solved

Functional benefit

Products and services

• Epilepsy Surgery (癫痫外科) Clinical department with 42 dedicated beds for the surgical treatment of epilepsy, including drug-resistant epilepsy, using ROSA planning, stereo-EEG, and laser ablation techniques. Targets adult and pediatric epilepsy patients whose conditions cannot be controlled by medication.
• Functional Neurosurgery (功能神经外科) Comprehensive surgical treatment for 30+ functional neurological conditions including Parkinson's disease, hemifacial spasm, trigeminal neuralgia, cerebral palsy, and Meige syndrome, using neuromodulation and stereotactic techniques.
• Skull Base Neurosurgery (颅底神经外科) Microsurgical resection of skull base and intracranial tumors, with over 7,400 intracranial tumor surgeries and nearly 200 clivus tumor resections completed. Targets patients with complex skull base tumors considered inoperable elsewhere.
• Supratentorial Tumor Surgery (幕上肿瘤外科) Surgical treatment of complex supratentorial tumors including pituitary tumors, craniopharyngioma, tuberculum sellae meningiomas, Rathke's cleft cysts, gliomas, and deep brain tumors.
• Cerebrovascular Surgery (脑血管外科) Clinical research and surgical treatment of intracranial aneurysms, cerebrovascular malformations, and stroke, including aneurysm clipping, AVM treatment, and bypass surgery.
• Neuroradiology and Interventional (神经介入科) Neurovascular interventional procedures including digital subtraction angiography (DSA), performing more than 50 interventional procedures monthly for conditions such as aneurysms and vascular malformations.
• Pediatric Neurosurgery (小儿神经外科) Surgical care for children with craniopharyngioma, vascular malformations, meningomyelocele, medulloblastoma, hydrocephalus, and spinal cord tethering, using age-appropriate techniques to preserve developmental potential.
• Spinal Cord and Spine Surgery (脊髓脊柱外科) Microsurgery combined with spinal internal fixation for spinal cord tumors, spinal deformities, spinal dysraphism, tethered cord, herniated discs, spinal stenosis, and spinal cord injuries.
• Endoscopic and Minimally Invasive Neurosurgery (内镜与微创神经外科) Minimally invasive endoscopic treatment of hydrocephalus, intraventricular lesions, intracranial arachnoid cysts, brain tumors, and trigeminal neuralgia.
• Neurology (神经内科) Inpatient and outpatient neurological care for epilepsy, neurodegenerative diseases, cerebrovascular diseases, and a wide range of other neurological disorders.
• Functional and Epilepsy Diagnosis and Treatment Center (功能及癫痫疾病诊疗中心) Multi-disciplinary center led by Professor Luan Guoming providing comprehensive evaluation, medical and surgical treatment of epilepsy, including pre-surgical evaluation and post-surgical follow-up.
• Craniopharyngioma Center (颅咽管瘤中心) Specialized center for surgical treatment of craniopharyngioma, achieving a 95% total resection rate across more than 1,200 cases — the most experienced team worldwide.
• Pituitary Tumor and Infertility Center (垂体瘤与不孕不育中心) Multi-hospital collaborative center treating infertility caused by pituitary factors using minimally invasive surgery for pituitary tumors.
• Neuro-Oncology Chemotherapy Center (神经肿瘤化疗中心) Chemotherapy services for malignant brain tumors including gliomas, medulloblastoma, germ cell tumors, and CNS lymphoma, integrated with neurosurgical and radiotherapy care.
• Cerebrovascular Center (脑血管中心) Comprehensive stroke and cerebrovascular disease center combining neurosurgery, neurology, and interventional neuroradiology for integrated prevention, acute treatment, and rehabilitation.
• Movement Disorder Regulation Center (运动障碍病调控诊疗中心) Multi-disciplinary center combining neurology, neurosurgery, rehabilitation, and neuropsychology for evaluation, surgical treatment (including DBS), and rehabilitation of Parkinson's and other movement disorders.
• Pain Rehabilitation Center (疼痛康复中心) Pain management services including spinal cord stimulation, intervertebral foramen endoscopy, and low-temperature plasma radiofrequency treatment for chronic pain conditions.
• Beijing Glioma Consultation Center (北京胶质瘤会诊中心) Multi-disciplinary glioma consultation center providing individualized treatment plans for complex brain glioma cases, integrating neurosurgery, radiotherapy, chemotherapy, and molecular pathology input.
• Sanbo Telemedicine Consultation Center (三博集团远程医疗会诊中心) Remote medical consultation service providing video consultations, multi-disciplinary remote consultation (MDT), and telepathology services to patients nationwide, particularly those unable to travel to Beijing.
• Magnetoencephalography Room (脑磁图室) Non-invasive brain function imaging using a 306-channel whole-head magnetoencephalography system for detection of small lesions and pre-surgical planning for epilepsy and tumor cases.
• Neuroradiology (神经影像科) Advanced neuroimaging services using MRI, CT, and DSA optimized for neurological diagnosis and pre-surgical planning.
• Sanbo Brain Research Institute (三博脑研所) Research institute conducting basic and translational neuroscience research including neurobiochemistry, molecular genetics, molecular pathology, and microsurgical anatomy, supporting clinical innovation.
• Drug Clinical Trial Institution (药物临床试验机构) Certified clinical trial institution conducting drug and medical device clinical trials in neurosurgery, neurology, pain management, and anesthesiology for sponsors and partners.

Quantifiable outcome

• 7,400+ intracranial tumor surgeries completed
• +4 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Beijing Borun Sunshine (北京博润阳光)coreStrategic or Co-development Partner · 16 July 2025Strategic cooperation agreement signed on July 16, 2025 to strengthen innovation in drug and medical device research and development, and to jointly promote high-quality development of clinical trials.
• Capital Medical University (首都医科大学)coreStrategic or Co-development PartnerAffiliated as the 11th Clinical Medical College (首都医科大学第十一临床医学院) and the third department of the Neurosurgery College (神经外科学院三系). Provides medical education, doctoral/master's supervisor programs, and postdoctoral research station.
• Beijing Tiantan Hospital (首都医科大学附属北京天坛医院)coreStrategic or Co-development PartnerCo-building unit of the Beijing Key Laboratory of Epilepsy Clinical Research, collaborating on epilepsy research and clinical applications.
• Beijing Brain Science and Brain-like Intelligence Industry Investment Fund (北京脑科学与类脑研究中心)coreStrategic or Co-development PartnerCollaborative research partner for brain science and brain-computer interface research, part of the Beijing Brain and Brain-machine Interface Key Laboratory initiative.
• National Medical Security Bureau (国家医疗保障局)coreOthersDesignated as a national cross-regional medical insurance settlement designated hospital, enabling patients from other provinces to use their medical insurance directly at the hospital.
• Haihe Pharmaceutical (海鹤制药)minorStrategic or Co-development PartnerCollaboration on clinical trials for brain tumor treatments and drug development.
• Medical Consortium Partners (医联体单位)minorChannel Partner/ Reseller/ DistributorMedical consortium partnerships with regional hospitals for patient referrals, training support, and collaborative diagnosis and treatment programs.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Phoenix Healthcare Group (凤凰医疗): Hong Kong-listed Chinese hospital group with hospital management and operation services. Comparable as a Chinese specialty/general hospital operator scaling a network model.
• Aier Eye Hospital Group (爱尔眼科): China's largest specialty hospital chain, operating in ophthalmology. Relevant comparable for Sanbo's multi-city specialty hospital chain model, though in a different clinical specialty.
• Topchoice Medical Corporation (通策医疗): Listed Chinese specialty hospital chain focused on dentistry. Provides a public-market comparable for specialty hospital chain economics and capital strategy.
• Jia Hui Medical Group (嘉会医疗): Shanghai-based private specialty healthcare group. Comparable as a private multi-specialty hospital chain operator in the Chinese tier-1 city market.

Direct peers

• Xuanwu Hospital (北京宣武医院): Capital Medical University-affiliated public hospital with a leading neurosurgery and neurology program in Beijing. Comparable in cerebrovascular and general neurosurgery patient mix.
• Shanghai Huashan Hospital (上海华山医院): Fudan University-affiliated hospital with a nationally ranked neurosurgery department. Comparable as a top-3 domestic competitor in complex cranial and skull base neurosurgery.
• Huaxi Hospital / West China Hospital (华西医院): Sichuan University-affiliated hospital operating one of China's largest neurosurgery programs. Comparable as a top-tier Chinese academic neurosurgery destination competing for complex referrals outside Beijing.
• Beijing Tiantan Hospital (北京天坛医院): Capital Medical University-affiliated public hospital and the historically dominant neurosurgery center in China. Directly comparable to Sanbo in neurosurgery, epilepsy, and skull base surgery, and is already a collaboration partner (Beijing Epilepsy Clinical Research Key Laboratory).
• Wuhan Tongji Hospital (武汉同济医院): Tongji Medical College-affiliated hospital with a strong neurosurgery department. Comparable in serving complex cranial neurosurgery cases and competing for central China referrals.

Regional players

• Max Healthcare (India): India-based specialty hospital chain with strong neurosurgery programs. Comparable as an emerging-market listed specialty hospital group pursuing branch expansion and capital-market growth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries9 records

Funding overview

Funding rounds2 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanbo Brain Hospital